"Q4 net sales SEK 2,296m (+10% vs ABGSCe 2,092m) up 22% organically (11% ABGSCe), Integrated solutions was even better than expected at 45% organic growth (ABGSCe 25%). Medical Solutions up 4% organic and in industrial solutions +10% organic. Group EBITA was SEK 249m (+8% vs ABGSCe 231m), on margin of 10.8% (ABGSCe 11.0%). Adjusted for SEK 22m negative one-offs EBITA was SEK 271m (+9% vs ABGSCe 248m) Net Income SEK 206m (ABGSCe SEK 170m)."

Link to commissioned research below.